Skip to main content

Knight Jeff E.'s Form 4 filing

Crinetics Pharmaceuticals, Inc. (CRNX) · filed Apr 10, 2026

Accession no.
0001628280-26-024716
Filed
Apr 10, 2026
Trade date
Apr 8, 2026
Filing delay
2 days
Rule 10b5-1 plan
Checked

This filing lists 4 non-derivative transactions and 3 derivative transactions. Open-market sales total $3.42M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Knight Jeff E.CIK 0001881007Officer (Chief Dev. & Operating Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Apr 8, 2026Common StockMOption exerciseAcquired+49,474$23.98+$1,186,386.52161,492Direct
Apr 8, 2026Common StockMOption exerciseAcquired+9,624$20.02+$192,672.48171,116Direct
Apr 8, 2026Common StockMOption exerciseAcquired+19,336$19.64+$379,759.04190,452Direct
Apr 8, 2026Common StockSSaleDisposed−85,163$40.10−$3,415,036.3105,289Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Apr 8, 2026Common StockMOption exerciseDisposed−49,474$0.00$063,027Direct
Apr 8, 2026Common StockMOption exerciseDisposed−9,624$0.00$010,589Direct
Apr 8, 2026Common StockMOption exerciseDisposed−19,336$0.00$065,977Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)